Company Profile (AI Text)
Name: Beta Bionics
Canonical URL: https://wefunder.com/beta.bionics
Updated at: 2026-06-02T05:00:05Z

Tagline: Building a bionic pancreas to improve the lives of people with type 1 diabetes
Elevator pitch: At Beta Bionics, Inc., we have developed a bionic pancreas called the iLet™, a pocket-sized, wearable medical device that autonomously manages blood sugar levels in people with diabetes. Our iLet technology has demonstrated dramatic improvements in clinical outcomes. Through its ability to continuously adapt to the ever-changing insulin needs of people with diabetes, the iLet is the quintessential embodiment of personalized medicine – a sturdy and irrevocable bridge to the ever-elusive cure.

Key claims:
- Total raised on Wefunder: 1000000 | citation: https://wefunder.com/beta.bionics#claim-total-raised
- Total investors: 718 | citation: https://wefunder.com/beta.bionics#claim-total-investors

Verified facts:
- Total raised on Wefunder: 1000000 | observed_at: 2026-06-02T05:00:05Z | expires_at: 2026-06-03T05:00:05Z
- Total investors: 718 | observed_at: 2026-06-02T05:00:05Z | expires_at: 2026-06-03T05:00:05Z

Computed metrics:
- total_amount_raised: 1000000
- total_investors: 718
- team_size: 9
- featured_investor_count: 0
- faq_count: 5
- recent_post_count: 1

Quick facts:
- 6 outpatient human clinical trials already completed. | citation: https://wefunder.com/beta.bionics#claim-fact-1
- Backed by nearly 10 years of clinical data. | citation: https://wefunder.com/beta.bionics#claim-fact-2

FAQ:
- Q: Hi, whats the valuation on the current fund raise?
  A: As a private company, valuing our security is a difficult task. Unlike public companies who actively trade stock in the public marketplace, there is no public market for Beta Bionics equity and there are no revenues to evaluate and inform any valuation. Accordingly, we have valued our security for this offering using an implied value based on recently completed third-party arm’s-length transaction with Eli Lilly & Company. In exchange for 5% of our stock, Eli Lilly & Company paid $5,0...
- Q: Can non USA residents invest?
  A: WeFunder is a global platform that has the capability of accepting investments from individuals and companies who are non-US residents. According to our understanding of the SEC regulations, Title III of the JOBS Act does not prevent non-US Citizens or residents from investing via a crowdfunding intermediary like WeFunder. We are not familiar with, and therefore cannot make any representations about, laws outside of the US which may prohibit such investments.
- Q: In your TED talk, you show that the device improves average daily blood glucose. However, this metric doesn't necessarily tell us much about the control that the device provides - spikes might not show up if they're compensated by nadirs, eg. Can you give a comparison of the a...
  A: Thanks for your very important question, Will. You are quite correct that mean blood glucose alone is not a good metric for control, which is why we typically use two co-primary outcomes in our studies: mean blood glucose AND time spent below 60 mg/dl. For example, in our 2013 and 2014 Summer Camp Studies and in our Multicenter Study, the bionic pancreas achieved a mean glucose of 142 +/- 12 mg/dl in adolescents, 137 +/- 11 mg/dl in pre-adolescents, and 141 +/- 12 mg/dl in adults, respectivel...
- Q: Hi, what's the valuation on the current fundraise?
  A: Great question and one we address in response to question 21 in Form C filed with the SEC. To recap, as a private company, valuing our security is a difficult task. Unlike public companies who actively trade stock in the public marketplace, there is no public market for Beta Bionics equity and there are no revenues to evaluate and inform any valuation. Accordingly, we have valued our security for this offering using an implied value based on recently completed third-party arm’s-length transac...
- Q: Is it an investment through SPV? Thx
  A: The offering by Beta Bionics is not done through a single-purpose vehicle (SPV), where a group of investors pool their capital in a fund, which in turn, invests the pooled capital as one entity in the startup company. Although the WeFund platform allows investment through an SPV, our offering is set up as a direct investment in Beta Bionics.

Recent posts:
- Beta Bionics Secures $57.6M Series B Round (2018-11-27T23:17:25Z) https://wefunder.com/feed/97399